October 2010 newsletter news: Victoza NICE for Type 2
NICE has issued its Final Appraisal Determination (FAD) on the use of Victoza (liraglutide) for people with type 2 diabetes in the UK, the only
NICE has issued its Final Appraisal Determination (FAD) on the use of Victoza (liraglutide) for people with type 2 diabetes in the UK, the only
OmegaForce is a specially formulated supplement which provides the body with the optimum combination of omega-3, -6 & -9 fatty acids for a multitude of
A Swiss study of mice has found that certain cells in the pancreas can regenerate themselves into insulin-producing cells after normal insulin-producing cells have been